glp 1 mechanism of action ppt Mechanisms and Therapeutic Application of Glucagon-like Peptide-1 List of GLP-1 Receptor Agonists

you can apply them anytime, anywhere, and nobody will even notice

The different ones GI discontinuation rate: 5.6% of semaglutide (Wegovy) users stopped due to GI side effects, vs 2.7% of Tirzepatide (Mounjaro) users Diarrhoea: Common with Mounjaro because of its dual action Nausea and constipation: Seen more in Wegovy MHRA NAION warning (February 2026) : Both medications carry an updated warning about a very rare but serious eye condition (non-arteritic anterior ischaemic optic neuropathy)

A friend on my crew had used BPC-157 for a shoulder issue and kept telling me to look into it

So your pituitary is either kaput, or you didnt do them properly

"Faster-acting drugs have a higher abuse potential," she went on